[6], 13 (3.7%) patients with stroke or systemic embolism and 124 (1.8%) event-free matched controls were taking rivaroxaban along with one P-gp/CYP3A4 inducer for a resulting adjusted OR of 2.02 (95% CI, 1.12-3.62). This evidence concerns the gene CYP3A4 and Stroke.